NanoSyrinx at Number 10
Our CEO Joe Healey was invited to Number 10 this week, to discuss the future of Engineering Biology in the UK as part of a networking and investment breakfast.
Synthetic biology or “Engineering Biology” has been highlighted as one of the five key technology areas for the UK’s future economy. Understanding how best to incubate, invest in, promote and unlock future innovations in the sector is therefore a high priority for policy makers and those in the industry.
The UK currently ranks third globally in total private investment in engineering biology and is home to more biotech start-ups than anywhere else in Europe. The UK Government is committed to building on this success, supporting more companies to start and scale in the UK and supporting our mission to become a science and technology superpower.
Engagement with companies and academics in the space is crucial to ensuring that this happens in the most optimal way.
